US46116X1019 - Common Stock
INTRA-CELLULAR THERAPIES INC
NASDAQ:ITCI (5/16/2024, 2:47:09 PM)
66.5
-0.34 (-0.51%)
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 561 full-time employees. The company went IPO on 2014-01-31. The firm is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company’s product CAPLYTA is a treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults as monotherapy and as adjunctive therapy with lithium or valproate. The efficacy of CAPLYTA 42 mg in bipolar depression was demonstrated in two positive Phase III placebo-controlled bipolar depression studies, which evaluated the effects of CAPLYTA on depression in adult patients with bipolar I or bipolar II disorder both as monotherapy (Study 404) and as adjunctive therapy with lithium or valproate (Study 402).
INTRA-CELLULAR THERAPIES INC
430 East 29th Street, Suite 900
New York City NEW YORK 10016
P: 16464409333
CEO: Sharon Mates
Employees: 561
ITCI stock results show that Intra-Cellular Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
CAPLYTA Q1 2024 net product sales were $144.8 million, compared to $94.7 million for the same period in 2023, representing a 53% increase CAPLYTA’s...
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company...
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.
Here you can normally see the latest stock twits on ITCI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: